New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences
Steady increase in worldwide prevalence of hypertension and hypertension-related cardiovascular morbidity and mortality necessitate new approaches to the management of hypertensive patients. It`s important to recognize that despite several differences the convergence of the 2017 ACC/AHA (US) and 201...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2019-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1866 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839641218203516928 |
|---|---|
| author | Zh. D. Kobalava E. A. Troitskaya E. L. Kolesnik |
| author_facet | Zh. D. Kobalava E. A. Troitskaya E. L. Kolesnik |
| author_sort | Zh. D. Kobalava |
| collection | DOAJ |
| description | Steady increase in worldwide prevalence of hypertension and hypertension-related cardiovascular morbidity and mortality necessitate new approaches to the management of hypertensive patients. It`s important to recognize that despite several differences the convergence of the 2017 ACC/AHA (US) and 2018 ESC/ESH (European) guidelines is greater now than ever before. The present review focuses on the key similarities and differences of these two documents. Among similarities we analyzed positions regarding the importance of cardiovascular risk evaluation for treatment initiation and choice of optimal treatment strategy: blood pressure (BP) treatment thresholds; drugs of choice for the initiation of antihypertensive therapy and treatment targets in different groups including elderly patients. Among key differences we analyzed sections concerning the classification of BP levels and target BP levels in patients with chronic kidney disease. In conclusion, we may say that in many ways the guidelines are just a different interpretation of the same data. There is no doubt in the importance of lowering high BP and evaluation and correction of high cardiovascular risk. One of the main purposes is to focus attention on younger patients with hypertension. |
| format | Article |
| id | doaj-art-8ff3fa2daadf4ef6a9b60ff44b4a84b9 |
| institution | Matheson Library |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2019-03-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-8ff3fa2daadf4ef6a9b60ff44b4a84b92025-07-03T07:28:35ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-03-0115110511410.20996/1819-6446-2019-15-1-105-1141581New Guidelines on Management of Arterial Hypertension: Key Similarities and DifferencesZh. D. Kobalava0E. A. Troitskaya1E. L. Kolesnik2Peoples’ Friendship University of Russia (RUDN University)Peoples’ Friendship University of Russia (RUDN University)Peoples’ Friendship University of Russia (RUDN University)Steady increase in worldwide prevalence of hypertension and hypertension-related cardiovascular morbidity and mortality necessitate new approaches to the management of hypertensive patients. It`s important to recognize that despite several differences the convergence of the 2017 ACC/AHA (US) and 2018 ESC/ESH (European) guidelines is greater now than ever before. The present review focuses on the key similarities and differences of these two documents. Among similarities we analyzed positions regarding the importance of cardiovascular risk evaluation for treatment initiation and choice of optimal treatment strategy: blood pressure (BP) treatment thresholds; drugs of choice for the initiation of antihypertensive therapy and treatment targets in different groups including elderly patients. Among key differences we analyzed sections concerning the classification of BP levels and target BP levels in patients with chronic kidney disease. In conclusion, we may say that in many ways the guidelines are just a different interpretation of the same data. There is no doubt in the importance of lowering high BP and evaluation and correction of high cardiovascular risk. One of the main purposes is to focus attention on younger patients with hypertension.https://www.rpcardio.online/jour/article/view/1866blood pressurearterial hypertensionantihypertensive therapyhypertension guidelinescardiovascular risk |
| spellingShingle | Zh. D. Kobalava E. A. Troitskaya E. L. Kolesnik New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences Рациональная фармакотерапия в кардиологии blood pressure arterial hypertension antihypertensive therapy hypertension guidelines cardiovascular risk |
| title | New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences |
| title_full | New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences |
| title_fullStr | New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences |
| title_full_unstemmed | New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences |
| title_short | New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences |
| title_sort | new guidelines on management of arterial hypertension key similarities and differences |
| topic | blood pressure arterial hypertension antihypertensive therapy hypertension guidelines cardiovascular risk |
| url | https://www.rpcardio.online/jour/article/view/1866 |
| work_keys_str_mv | AT zhdkobalava newguidelinesonmanagementofarterialhypertensionkeysimilaritiesanddifferences AT eatroitskaya newguidelinesonmanagementofarterialhypertensionkeysimilaritiesanddifferences AT elkolesnik newguidelinesonmanagementofarterialhypertensionkeysimilaritiesanddifferences |